Tag: #Global Trends

Bristol Myers Squibb (BMS) has announced a major collaboration and licensing agreement with China-based Hengrui Pharma. The deal covers 13... Read more

Bristol Myers Squibb (BMS) has formed a broad partnership with Hengrui Pharma in a deal potentially worth up to $15.2... Read more

Eli Lilly and Company has announced a further $4.5 billion investment across two of its sites in Lebanon, Indiana. This... Read more

Pharmaceutical giant GSK has entered into an exclusive collaboration with Sino Biopharmaceutical (SBP Group), specifically through its subsidiary Chia Tai... Read more

Johnson & Johnson has introduced a new advocacy project titled "Generation Fine," aimed at reshaping the conversation around clinical depression.... Read more

AstraZeneca has confirmed an extension of its technical partnership with the biotech firm Immunai, committing up to $37.5 million in... Read more

Bristol Myers Squibb (BMS) has announced that the European Commission (EC) has approved Sotyktu (deucravacitinib) for the treatment of active... Read more

Gilead Sciences has revised its 2026 sales forecast for Yeztugo (lenacapivir), its twice-yearly HIV pre-exposure prophylaxis (PrEP) medication. Following a... Read more

Kenvue Inc., the maker of Tylenol, beat Wall Street estimates for first-quarter revenue and profit on Thursday. The positive performance... Read more